ALLERGAN LIMITED - GB 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 31.041.950 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASTRAZENECA2
JANSSEN PHARMACEUTICA NV2
NOVARTIS PHARMA2
PFIZER LIMITED2
SANOFIAVENTIS2
TEVA PHARMACEUTICAL INDUSTRIES LIMITED2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
BAYER1
BERRY CONSULTANTS LLP1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHILDREN'S TUMOR FOUNDATION1
COVANCE CLINICAL AND PERIAPPROVAL SERVICES1
CUSTODIX NV1
DOCUMENTAL OU1
DREEM1
EATRIS ERIC1
ECLINICALHEALTH1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROSCAN INTERNATIONAL NETWORK EV1
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL1
FH JOANNEUM GESELLSCHAFT MBH1
FORUM DES PATIENTS EUROPEENS1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
IQVIA RDS FRANCE1
JULIUS CLINICAL RESEARCH BV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MEDICAL RESEARCH NETWORK LIMITED1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDTRONIC INTERNATIONAL TRADING SARL1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
NOVO NORDISK1
OTSUKA NOVEL PRODUCTS1
SPRINGWORKS THERAPEUTICS INC1
STICHTING LYGATURE1
STICHTING MLC FOUNDATION1
STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY1
SYDDANSK UNIVERSITET1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TEAM IT RESEARCH SL1
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA1
THE UNIVERSITY OF MANCHESTER1
UCB BIOPHARMA1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF DUNDEE1
UNIVERSITY OF NEWCASTLE UPON TYNE1
VITAL TRANSFORMATION1

Constancy:

Total number of partners: 68
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 68
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833